The first Global Brain Development Science Summit was successfully held, with Feihe helping the next generation become smarter.

On October 22, the inaugural Tan Jiazhen Foundation - China Feihe Global Brain Development Science Summit was grandly held in Beijing. As the first international scientific event focusing on brain development, the summit successfully attracted experts and scholars from numerous research institutions and universities, including the Chinese Academy of Sciences, the Chinese Academy of Engineering, Harvard Medical School, Yale University, Peking University, and Capital Medical University. They gathered together to discuss cutting-edge research and achievements in early-life brain development.

At the summit, Feihe $CHINA FEIHE(06186.HK) announced the establishment of a global R&D platform and formed a strategic partnership with Capital Medical University. Meanwhile, Feihe also released its latest scientific achievements, including the first maternal nutritional product designed to promote fetal neural development. As a leader in the infant formula industry, Feihe has consistently focused on brain development and nutrition research, leveraging its strengths to actively fulfill social responsibilities. In collaboration with the Shanghai Magnolia Tan Jiazhen Life Science Development Foundation, Feihe organized this international academic event to facilitate cross-border resource sharing and academic exchange, deepen industry-academia-research-medicine integration, accelerate the translation of brain development and nutrition research findings, and contribute to global health advancements.

At the summit, authoritative experts from around the world gathered to discuss frontier topics in brain development. According to the World Health Organization (WHO), the first 1,000 days of life represent a "window of opportunity" for individual growth and intellectual development, laying a solid foundation for lifelong health and cognitive abilities. China's "Healthy China 2030" plan also explicitly emphasizes improving maternal and child health and strengthening early childhood development. The "National Nutrition Plan (2017–2030)" issued by the State Council highlights the "First 1,000 Days Nutrition and Health Action," elevating early-life nutrition to a national priority.

Takao Hensch, Professor of Neurology at Boston Children's Hospital, Harvard Medical School, emphasized at the conference: "There are critical periods in brain development that profoundly impact a person's life. Most of these critical periods occur during infancy and early childhood when the brain exhibits high plasticity. A nurturing environment and adequate nutritional support can effectively promote brain development. We appreciate Feihe's support for Harvard Boston Children's Hospital, as the limitless potential of the brain is humanity's most precious resource."

Lin Lu, Academician of the Chinese Academy of Sciences and President of Peking University Sixth Hospital, pointed out that nutrition provides essential material support for brain and neural function development in early life. He stressed that sufficient and balanced nutrient intake is crucial for ensuring healthy growth in infants and young children. "Brain health is a cornerstone of social well-being and the foundation for individual growth, maturity, and success. We need societal forces, including visionary organizations like the Tan Jiazhen Foundation and responsible enterprises like China Feihe Dairy, to invest resources in scientific research."

Xunming Ji, Academician of the Chinese Academy of Engineering and Vice President of Capital Medical University, stated that brain health is central to life health. He analyzed the current state of brain health in China and commended Feihe's corporate responsibility. He expressed that Capital Medical University would collaborate with Feihe to bridge the "last mile" in translating scientific achievements into practical applications, accelerating the implementation of more research outcomes.

As a leader in the infant formula industry, Feihe adheres to a long-term approach, continuously innovating in dairy product R&D and achievement translation. Feihe has undertaken China's "14th Five-Year Plan" key R&D project, leading the development of the "next-generation infant formula." Focusing on areas such as breast milk and brain nutrition, the gut-brain axis, and brain cognition and disease intervention, Feihe has produced a series of internationally advanced research outcomes, publishing nine high-level papers in authoritative journals, one professional book, and filing 20 patents related to brain development nutrition.

At the summit, Jiang Shilong, Chief Scientist of China Feihe, introduced Feihe's latest research findings on brain development nutrition. DHA and ARA are key components in breast milk that support brain development, but their proportions matter—excessive or imbalanced amounts can lead to competitive inhibition, negatively affecting infant brain development. Based on over a decade of research on Chinese breast milk composition, Feihe discovered that the optimal DHA-to-ARA ratio in Chinese breast milk is 1:1.7, differing significantly from ratios in the U.S. and Japan. Clinical feeding trials conducted in collaboration with professional institutions confirmed that infants fed with formula containing five major brain phospholipids and a DHA:ARA ratio of 1:1.7 exhibited superior neurodevelopmental performance in their first year. These findings have been applied across Feihe's infant formula product line, enabling more Chinese babies to benefit from the latest research and achieve better brain development.

"In the future, we will leverage core research platforms such as Peking University Health Science Center, Jiangnan University, and Harvard BCH in the U.S., along with European partners in nutrition, to build a global R&D platform spanning Asia, America, and Europe. Through international collaboration, we will accelerate resource sharing and technological innovation to deliver higher-quality brain nutrition products," said Jiang Shilong.

Following collaborations with top-tier institutions like Peking University Health Science Center, Boston Children's Hospital at Harvard Medical School, and Tsinghua University's Brain and Intelligence Laboratory, Feihe established a strategic partnership with Capital Medical University at the summit. The two parties will jointly build a research collaboration platform, focusing on functional nutrition and brain health across the lifespan, including studies on adult functional nutrition products like "Aiben," to expand brain research and improve national health nutrition.

Precision nutrition solutions support early-life brain development. Pregnancy marks the beginning of the first 1,000 days, and Feihe is committed to raising public awareness of the importance of brain development. In collaboration with the China Healthy Birth Association and Life Times, Feihe released the first "White Paper on Chinese Children's Brain Development," providing scientific data and insights into parents' understanding and misconceptions about early brain development to offer guidance and support for healthier and smarter growth in infants and young children.

From pioneering the "whole industry chain" model to ensure the safety of every Chinese baby's food to creating innovative products "more suitable for Chinese babies' physiques," Feihe has set benchmarks and continues to lead the direction of China's dairy industry.